| Literature DB >> 29340742 |
D Huster1.
Abstract
Wilson disease is a rare hereditary disorder of copper metabolism. The genetic defect is caused by various mutations in the copper-transporting enzyme ATP7B, located mainly in the liver and brain. Clinical symptoms are highly variable, with any combination of hepatic and/or neurological or psychiatric manifestations. The age of onset varies from early childhood to young adults and can even be manifested in later ages. The clinical diagnosis is based on a combination of clinical, biochemical and molecular markers. Treatment using chelating agents and zinc salts is effective when started early or even better at presymptomatic stages of the disease.Entities:
Keywords: Central nervous system; Chelating agents; Copper toxicity; Liver; Wilson disease protein
Mesh:
Substances:
Year: 2018 PMID: 29340742 DOI: 10.1007/s00108-017-0378-x
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743